Pacific Channel Offers - Follow Up Rounds
Further to my last newsletter, here’s a list of some of the investment opportunities being offered by Pacific Channel. Some of these you may have seen before, and now all 3 of them, Footfalls & Heartbeats, Engender, and D’Arcy Polychrome, are seeking their next capital rounds.
Footfalls and Heartbeats – New Licensing Agreement Secured
Having secured a multi-million dollar licensing agreement with global medical compression company, medi, Footfalls & Heartbeats (FHL) is now raising new capital for its next phase of growth. The minimum being sought is $1,000,000 of which $750,000 is already committed by existing and new wholesale investors. The company can accept up to $2,000,000 of new investment through this offer.
FHL has developed a proprietary process for manufacturing smart textiles to improve healthcare and sports performance at low cost. FHL has already secured a multi-million dollar deal and is well positioned to become a key enabling technology player in the rapidly growing smart textile market. FHL’s proprietary process manufactures smart fabrics proven to measure in real-time compressive force and tensile force, which it can license to multiple large established companies leaders in their respective fields. FHL uses interactions within the textile structure to make the fabric itself the sensor, thus avoiding the need for wires or miniature electronics in the sensing area.
The global commitment from its first licensee, medi, has validated FHL’s potential in the smart textiles market, generating interest from multiple global companies from varying industries. The interest signals FHL’s diverse potential with its proprietary process for manufacturing smart textiles. In recent months Letters of Intent have been signed with a clinical bed company, a wheelchair seat company and a global technical fabrics company focused on public transport and truck seats.
The new capital will be allocated across a number of priorities to enable this next phase of growth. Delivery of the first order of product to medi takes precedence, with funding also going into business development with the interested potential licensees. This will assist with licensed product applications, patent application(s), materials, prototype knitting and electronics design. See article in Sunday Star Times.
Engender – Support of one of the World’s Largest AI Companies Secured
Engender has secured the support of one of the world’s largest cow artificial insemination (AI) companies which is backing Engender in a multi-stage deal. It has already provided US$250,000 of resources upfront in return for the option to license the technology, and may provide a further potential US$1.5 million of investment and resources.
Engender is a New Zealand company that has developed a proprietary process to separate X (female) and Y (male) bearing bull sperm cells to enable cattle farmers to choose the sex of offspring. The initial target is the dairy industry. See NZ Herald article.
Engender is well positioned to become a key player in the international animal breeding industry with an affordable and effective sperm sex sorting product. The world market for AI is estimated to be about US$2.4 billion (dairy 65%, beef 10% and swine 25%). Engender’s addressable market is estimated at over US$500 million.
Engender is raising $2,500,000 for 35% of the Company, with oversubscriptions accepted up to $3,000,000 in aggregate. Engender has secured cash and commitments for $335,000 as part of this offer.
D’Arcy Polychrome - Sales
Agreement with Ixom Secured
Following strong interest in the US from leading architecture and design
customers like Dwell magazine, D’Arcy Polychrome Limited (DPL) is raising a
further $2,000,000 of new equity investment to fund the commercialisation of
drikolor as a patented high margin colouring system for paint and concrete.
The company’s technology opens up the opportunity to sell colour to a range of homeware stores, designers and online channels that haven’t sold these mediums before, and gives them the potential to curate their own colour palettes. The secret is in its delivery. D’Arcy has patented a process to create colour through dry granulated pigments that rapidly mix into base paints and concrete. The colours produced achieve very specific tinting easily and reliably at point of sale or at point of use.
See the interview with the founder Rachel Lacy.
DPL has already secured a sales agreement including upfront sales, with Ixom (formerly Orica), which sells its colourant technology exclusively in New Zealand for concrete. The new capital will be used to build a sales and marketing team to execute on opportunities primarily in the United States.
DPL is raising $2,000,000 for 18.26% of the Company. DPL has secured cash and commitments for $620,000 as part of this offer.
.......................................................................................................................................................
The above investments are not offers of financial products that requires disclosure under the Financial Markets Conduct Act 2013 (Act) and are available only to wholesale investors as defined in Schedule 1 of that Act (other than any person who is only a "wholesale investor" under clause 3(3)(b)(i) or (ii) of Schedule 1 of that Act). They are intended for distribution only to selected people to whom, under the relevant laws, they can be lawfully distributed. They cannot be distributed in any other jurisdiction, or to any other people. They are not offers or solicitations in any jurisdiction in which such offers or solicitations are not authorised, or in which the person making such offers or solicitations are not qualified to do so, or to any person to whom it is unlawful to make such offers or solicitations. Any representation to the contrary would be unlawful. No action has been taken by any person that would permit a public offering in any jurisdiction where action for that purpose would be required.
CheersJP
John Paine B.Sc., Dip BIA
TBK Capital Limited
Level 15, BDO Building
120 Albert Street
Auckland 1010, New Zealand
Phone +64 9 307 3257
Fax +64 9 309 4519
Mobile +64 21 902 901
Email john.paine@tbkcapital.co.nz
⇑ back to top